Drugs Made In America Acquisition II Corp. (DMIIR)

Nasdaq: DMIIR · CIK 0002040475 · United States

Every official Drugs Made In America Acquisition II Corp. filing in one place: annual reports, quarterly results, current reports, proxy statements, shareholding and announcements, straight from the regulator. Free to search.

Open DMIIR filings

Drugs Made In America Acquisition II Corp. documents

Drugs Made In America Acquisition II Corp. 10-K 2026DMIIR 10-K 2026: annual report for fiscal 2026
Drugs Made In America Acquisition II Corp. 10-K 2025DMIIR 10-K 2025: annual report for fiscal 2025
Drugs Made In America Acquisition II Corp. 10-K 2024DMIIR 10-K 2024: annual report for fiscal 2024
Drugs Made In America Acquisition II Corp. 10-K 2023DMIIR 10-K 2023: annual report for fiscal 2023
Drugs Made In America Acquisition II Corp. 10-K 2022DMIIR 10-K 2022: annual report for fiscal 2022
Drugs Made In America Acquisition II Corp. 10-Q 2026DMIIR 10-Q 2026: quarterly report for fiscal 2026
Drugs Made In America Acquisition II Corp. 10-Q 2025DMIIR 10-Q 2025: quarterly report for fiscal 2025
Drugs Made In America Acquisition II Corp. 10-Q 2024DMIIR 10-Q 2024: quarterly report for fiscal 2024
Drugs Made In America Acquisition II Corp. 10-Q 2023DMIIR 10-Q 2023: quarterly report for fiscal 2023
Drugs Made In America Acquisition II Corp. 10-Q 2022DMIIR 10-Q 2022: quarterly report for fiscal 2022
Drugs Made In America Acquisition II Corp. 8-K 2026DMIIR 8-K 2026: current report for fiscal 2026
Drugs Made In America Acquisition II Corp. 8-K 2025DMIIR 8-K 2025: current report for fiscal 2025
Drugs Made In America Acquisition II Corp. 8-K 2024DMIIR 8-K 2024: current report for fiscal 2024
Drugs Made In America Acquisition II Corp. 8-K 2023DMIIR 8-K 2023: current report for fiscal 2023
Drugs Made In America Acquisition II Corp. 8-K 2022DMIIR 8-K 2022: current report for fiscal 2022
Drugs Made In America Acquisition II Corp. DEF 14A 2026DMIIR DEF 14A 2026: proxy statement for fiscal 2026
Drugs Made In America Acquisition II Corp. DEF 14A 2025DMIIR DEF 14A 2025: proxy statement for fiscal 2025
Drugs Made In America Acquisition II Corp. DEF 14A 2024DMIIR DEF 14A 2024: proxy statement for fiscal 2024
Drugs Made In America Acquisition II Corp. DEF 14A 2023DMIIR DEF 14A 2023: proxy statement for fiscal 2023
Drugs Made In America Acquisition II Corp. DEF 14A 2022DMIIR DEF 14A 2022: proxy statement for fiscal 2022
Drugs Made In America Acquisition II Corp. Form 4 2026DMIIR Form 4 2026: insider trading filing for fiscal 2026
Drugs Made In America Acquisition II Corp. Form 4 2025DMIIR Form 4 2025: insider trading filing for fiscal 2025
Drugs Made In America Acquisition II Corp. Form 4 2024DMIIR Form 4 2024: insider trading filing for fiscal 2024
Drugs Made In America Acquisition II Corp. Form 4 2023DMIIR Form 4 2023: insider trading filing for fiscal 2023
Drugs Made In America Acquisition II Corp. Form 4 2022DMIIR Form 4 2022: insider trading filing for fiscal 2022
Drugs Made In America Acquisition II Corp. S-1 2026DMIIR S-1 2026: registration statement for fiscal 2026
Drugs Made In America Acquisition II Corp. S-1 2025DMIIR S-1 2025: registration statement for fiscal 2025
Drugs Made In America Acquisition II Corp. S-1 2024DMIIR S-1 2024: registration statement for fiscal 2024
Drugs Made In America Acquisition II Corp. S-1 2023DMIIR S-1 2023: registration statement for fiscal 2023
Drugs Made In America Acquisition II Corp. S-1 2022DMIIR S-1 2022: registration statement for fiscal 2022
Drugs Made In America Acquisition II Corp. 13F 2026DMIIR 13F 2026: institutional holdings for fiscal 2026
Drugs Made In America Acquisition II Corp. 13F 2025DMIIR 13F 2025: institutional holdings for fiscal 2025
Drugs Made In America Acquisition II Corp. 13F 2024DMIIR 13F 2024: institutional holdings for fiscal 2024
Drugs Made In America Acquisition II Corp. 13F 2023DMIIR 13F 2023: institutional holdings for fiscal 2023
Drugs Made In America Acquisition II Corp. 13F 2022DMIIR 13F 2022: institutional holdings for fiscal 2022

More companies